In the past week, TCRX stock has gone down by -8.75%, with a monthly gain of 17.74% and a quarterly ...
Wall Street Zen cut shares of TScan Therapeutics from a "hold" rating to a "sell" rating in a report...
Wellington Management Group LLP grew its position in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX...
TScan Therapeutics, Inc. (NASDAQ:TCRX – Get Free Report) saw a large increase in short interest in t...
WALTHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical...